drugset / Trial / NCT00234936
Quality of Life Study With Adalimumab in Rheumatoid Arthritis
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to evaluate the ability of adalimumab combined with methotrexate to improve the quality of life in patients with active RA.
Timeline
- Start
- 2003-12
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adalimumab | Monoclonal antibody | — | — |
| Subject | Methotrexate | Small molecule | — | — |